INLB
Item 9 Labs Corp
Price:  
0.00 
USD
Volume:  
10,830.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INLB EV/EBITDA

-11114037.1%
Upside

As of 2026-04-04, the EV/EBITDA ratio of Item 9 Labs Corp (INLB) is -4.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INLB's latest enterprise value is 33.72 mil USD. INLB's TTM EBITDA according to its financial statements is -7.20 mil USD. Dividing these 2 quantities gives us the above INLB EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.3x - 9.6x 7.4x
Forward P/E multiples 4.2x - 8.4x 4.9x
Fair Price (0.10) - (0.13) (0.11)
Upside -10262537.5% - -13442837.3% -11114037.1%
0.00 USD
Stock Price
(0.11) USD
Fair Price

INLB EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-16 -4.68
2026-02-23 -4.68
2026-02-03 -4.68
2026-01-14 -4.68